Sandu Pharmaceuticals Q3 Results

  • BSE: 524703
  • NSE: -
  • ISIN: INE751D01014
  • Sector: Biotechnology & Drugs
BSE
38.200.19 (0.50%)
Volume794.00
Updated: Wed 10 Dec, 2025 | 14:26:15
NSE
This stock is not traded on NSE
Today: 38.20
42.00
52-Wk: 37.00
62.80

Q3 Results Highlights

    Note: Comparison is on QoQ basis

    Quarterly - Sandu Pharmaceuticals Q3 Results

    *All figures in crores except per share values
    Fiscal PeriodDec 24Sep 24QoQ CompDec 23YoY Comp
    Total Operating Expense 17.5716.973.55%17.063.00%
    Depreciation/ Amortization 0.190.178.90%0.1433.80%
    Operating Income 0.800.748.81%0.37117.36%
    Net Income 0.560.5012.15%0.21169.01%
    Other Operating Expenses Total 5.366.03-11.01%5.76-6.87%
    Net Income Before Taxes 0.800.748.34%0.38111.30%
    Total Revenue 18.3717.703.77%17.435.42%
    Selling/ General/ Admin Expenses Total 3.162.6121.07%2.5324.60%
    Diluted Normalized EPS 0.571.95-70.77%0.21171.43%
    Recommended For You

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe

        Trending Now In Market